rs387906998

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_003477.3(PDHX):​c.44G>A​(p.Arg15His) variant causes a missense change. The variant allele was found at a frequency of 0.00025 in 1,612,796 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 2 hom. )

Consequence

PDHX
NM_003477.3 missense

Scores

1
7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:1

Conservation

PhyloP100: 4.22
Variant links:
Genes affected
PDHX (HGNC:21350): (pyruvate dehydrogenase complex component X) The pyruvate dehydrogenase (PDH) complex is located in the mitochondrial matrix and catalyzes the conversion of pyruvate to acetyl coenzyme A. The PDH complex thereby links glycolysis to Krebs cycle. The PDH complex contains three catalytic subunits, E1, E2, and E3, two regulatory subunits, E1 kinase and E1 phosphatase, and a non-catalytic subunit, E3 binding protein (E3BP). This gene encodes the E3 binding protein subunit; also known as component X of the pyruvate dehydrogenase complex. This protein tethers E3 dimers to the E2 core of the PDH complex. Defects in this gene are a cause of pyruvate dehydrogenase deficiency which results in neurological dysfunction and lactic acidosis in infancy and early childhood. This protein is also a minor antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC eventually leads to cirrhosis and liver failure. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014390051).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000125 (19/152310) while in subpopulation SAS AF= 0.00352 (17/4828). AF 95% confidence interval is 0.00224. There are 1 homozygotes in gnomad4. There are 11 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDHXNM_003477.3 linkc.44G>A p.Arg15His missense_variant Exon 1 of 11 ENST00000227868.9 NP_003468.2 O00330-1
PDHXNM_001166158.2 linkc.44G>A p.Arg15His missense_variant Exon 1 of 6 NP_001159630.1 O00330-2
PDHXNM_001135024.2 linkc.-21+213G>A intron_variant Intron 1 of 10 NP_001128496.2 O00330
PDHXXM_011520390.2 linkc.-21+761G>A intron_variant Intron 1 of 10 XP_011518692.1 A0A8C8MSB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDHXENST00000227868.9 linkc.44G>A p.Arg15His missense_variant Exon 1 of 11 1 NM_003477.3 ENSP00000227868.4 O00330-1

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152192
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.000554
AC:
138
AN:
248950
Hom.:
0
AF XY:
0.000726
AC XY:
98
AN XY:
135078
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00405
Gnomad FIN exome
AF:
0.0000479
Gnomad NFE exome
AF:
0.0000621
Gnomad OTH exome
AF:
0.000991
GnomAD4 exome
AF:
0.000263
AC:
384
AN:
1460486
Hom.:
2
Cov.:
59
AF XY:
0.000390
AC XY:
283
AN XY:
726554
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00376
Gnomad4 FIN exome
AF:
0.0000570
Gnomad4 NFE exome
AF:
0.0000342
Gnomad4 OTH exome
AF:
0.000249
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152310
Hom.:
1
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000947
Bravo
AF:
0.0000302
ExAC
AF:
0.000535
AC:
65
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pyruvate dehydrogenase E3-binding protein deficiency Pathogenic:1Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 21, 2011
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

not provided Uncertain:1Benign:1
Nov 02, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 15 of the PDHX protein (p.Arg15His). This variant is present in population databases (rs387906998, gnomAD 0.4%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with pyruvate dehydrogenase deficiency (PMID: 21937992). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30752). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Mar 03, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 21937992) -

not specified Uncertain:1
Aug 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: PDHX c.44G>A (p.Arg15His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00055 in 248950 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in PDHX causing Pyruvate Dehydrogenase E3-Binding Protein Deficiency (0.00055 vs 0.0011), allowing no conclusion about variant significance. c.44G>A has been reported in the literature in a family affected with intellectual disability (example: Najmabadi_2011). This report does not provide unequivocal conclusions about association of the variant with Pyruvate Dehydrogenase E3-Binding Protein Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 21937992). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS (n=2) and likely benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.062
T
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;.;.
Eigen
Benign
0.020
Eigen_PC
Benign
-0.013
FATHMM_MKL
Benign
0.46
N
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.014
T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Uncertain
2.2
M;M;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.3
N;N;N
REVEL
Benign
0.27
Sift
Uncertain
0.0080
D;D;D
Sift4G
Uncertain
0.016
D;D;D
Polyphen
0.021
B;.;.
Vest4
0.55
MutPred
0.76
Loss of MoRF binding (P = 0.0079);Loss of MoRF binding (P = 0.0079);Loss of MoRF binding (P = 0.0079);
MVP
0.60
MPC
0.24
ClinPred
0.081
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs387906998; hg19: chr11-34938246; API